Company Data

Stereotaxis Inc – Ordinary Shares

Current Price
$2.07 -4.17%
Market Cap
Price Target
Refer to Report
52wk Range
$1.55 - $2.7452
Advanced Market Data


Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company’s mission is the discovery, development and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. Over 100 issued patents support the company platform. The core components of its systems have received regulatory clearance including United States, European Union, Japan, Canada, and China.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.